A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
formats

Second Sight Receives FDA Clearance for Argus II Retinal Prosthesis

On February 4, 2013, after more than 20 years of research and development, Second Sight Medical Products, Inc., announced that its Argus® II Retinal Prosthesis System (“Argus II”) has received U.S. market approval from the Food and Drug Administration (FDA) to treat individuals with late stage retinitis pigmentosa (RP). This announcement follows receipt of the European

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Second Sight Receives FDA Clearance for Argus II Retinal Prosthesis  comments